niacinamide has been researched along with ketamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Adams, JD; Chan, PH; Chang, ML; Kem, S; Klaidman, L; Sugawara, T; Yang, J | 1 |
| Ahmed, J; Kim, MO; Lee, HY; Naseer, MI; Seok, PM; Ullah, I; Ullah, N | 1 |
| Henter, ID; Lepow, L; Luckenbaugh, DA; Park, L; Zarate, CA | 1 |
4 other study(ies) available for niacinamide and ketamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Nicotinamide and ketamine reduce infarct volume and DNA fragmentation in rats after brain ischemia and reperfusion.
Topics: Animals; Brain Ischemia; Cerebral Infarction; DNA Fragmentation; Excitatory Amino Acid Antagonists; Ketamine; Male; Middle Cerebral Artery; Niacinamide; Nicotinic Agonists; Rats; Rats, Wistar; Reperfusion Injury | 2002 |
Protective function of nicotinamide against ketamine-induced apoptotic neurodegeneration in the infant rat brain.
Topics: Anesthetics, Dissociative; Animals; Animals, Newborn; Apoptosis; Ketamine; Nerve Degeneration; Neuroprotective Agents; Niacinamide; Prosencephalon; Rats; Rats, Sprague-Dawley; Vitamin B Complex | 2012 |
Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects.
Topics: Adamantane; Adult; Antidepressive Agents; Depression; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Memantine; Middle Aged; Niacinamide; Predictive Value of Tests; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2017 |